Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation | Patent Number 09101621

US 09101621 B2
Application Number14255211
Publication NumberUS 20140308344 A1
Pendency1 year, 3 months, 26 days
Filled DateApr 17, 2014
Priority DateMay 17, 2002
Publication DateOct 16, 2014
Expiration DateMay 17, 2022
Inventor/ApplicantsJerome B. Zeldis
ExaminesSIMMONS, CHRIS E
Art Unit1629
Technology Center1600
Assignments
Celgene
Current
CelgeneBristol Myers Squibb
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.